Valiant Laboratories Limited
NSE: VALIANTLAB.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Santosh Shantilal Vora
- Employees
- 77
- Headquarters
- Mumbai, India
- IPO year
- 2023
- Market cap
- ₹4.3B
- Website
- https://valiantlabs.in
Loading VALIANTLAB…
Loading profile data…Frequently asked questions about VALIANTLAB
What does Valiant Laboratories Limited (VALIANTLAB.NS) do?
Valiant Laboratories Limited operates as an active pharmaceutical ingredient/bulk drug manufacturing company in India and internationally. The company manufactures paracetamol in various grades, such as Indian/British/European/the United States pharmacopeias for the treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold, a...
Where does VALIANTLAB.NS trade?
Valiant Laboratories Limited (VALIANTLAB.NS) trades on the National Stock Exchange of India.
What sector is VALIANTLAB.NS in?
Valiant Laboratories Limited (VALIANTLAB.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Valiant Laboratories Limited?
Santosh Shantilal Vora is the chief executive officer of Valiant Laboratories Limited (VALIANTLAB.NS).
Where is Valiant Laboratories Limited headquartered?
Valiant Laboratories Limited is headquartered in India.
Does VALIANTLAB.NS pay a dividend?
Valiant Laboratories Limited (VALIANTLAB.NS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did VALIANTLAB.NS go public?
Valiant Laboratories Limited (VALIANTLAB.NS) completed its initial public offering in 2023.